Aligos Therapeutics Inc. (ALGS): Price and Financial Metrics
ALGS Price/Volume Stats
| Current price | $0.83 | 52-week high | $1.38 |
| Prev. close | $0.82 | 52-week low | $0.54 |
| Day low | $0.79 | Volume | 644,251 |
| Day high | $0.87 | Avg. volume | 357,374 |
| 50-day MA | $0.90 | Dividend yield | N/A |
| 200-day MA | $0.80 | Market Cap | 62.73M |
ALGS Stock Price Chart Interactive Chart >
Aligos Therapeutics Inc. (ALGS) Company Bio
Aligos Therapeutics, Inc. develops targeted, curative therapies for hepatologic diseases and viral infections. It engages in building a pipeline of drug candidates which targets multiple clinically validated mechanisms of action and are designed to achieve functional cure for CHB and become transformative treatment options for COVID-19 and NASH. The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA.
Latest ALGS News From Around the Web
Below are the latest news stories about ALIGOS THERAPEUTICS INC that investors may wish to consider to help them evaluate ALGS as an investment opportunity.
Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)SOUTH SAN FRANCISCO, Calif., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, delivered oral presentations of clinical data for its capsid assembly modulator-empty (CAM-E), ALG-000184, and its thyroid hormone receptor-beta (THR-β) drug candidate, ALG-055009, at the Hep-DART 2023 meeting, held in Cabo San Lucas, Mexico, from Dec |
13 Stocks Insiders are Buying NowIn this article, we will take a look at the 13 stocks insiders are buying now. To see more such companies, go directly to 5 Stocks Insiders are Buying Now. With the end of 2023 now in sight, many can say with confidence that the much-dreaded recession everyone was talking about will not realize this […] |
Why Is Aligos Therapeutics (ALGS) Stock Down 5% Today?Aligos Therapeutics stock is falling alongside news of a secondary offering for ALGS that it won't see any proceeds of the sales from. |
Why Is Tharimmune (THAR) Stock Down 8% Today?Tharimmune stock is falling after the company announced a reverse stock split for THAR shares that goes into effect later today. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start the week with a breakdown of the biggest pre-market stock movers traders need to watch on Monday morning! |
ALGS Price Returns
| 1-mo | -11.58% |
| 3-mo | 18.57% |
| 6-mo | 34.20% |
| 1-year | -19.42% |
| 3-year | -96.61% |
| 5-year | N/A |
| YTD | 25.00% |
| 2023 | -30.32% |
| 2022 | -91.97% |
| 2021 | -57.07% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...